Morris, L., Mkhize, N. N., Hermanus, T., Chung, E., Sato, A., Grant, S., … Gray, G. (2013). Boosting Antibody Responses with gp140 Protein Two Years After DNA/MVA Priming: Results from the HVTN 073E Phase I Vaccine Trial. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 29, pp. A171–A171). Barcelona, SPAIN: MARY ANN LIEBERT, INC.

Morris, L., N. N. Mkhize, T. Hermanus, E. Chung, A. Sato, S. Grant, N. Gu, et al. “Boosting Antibody Responses with gp140 Protein Two Years After DNA/MVA Priming: Results from the HVTN 073E Phase I Vaccine Trial.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 29:A171–A171. MARY ANN LIEBERT, INC, 2013.

Morris L, Mkhize NN, Hermanus T, Chung E, Sato A, Grant S, et al. Boosting Antibody Responses with gp140 Protein Two Years After DNA/MVA Priming: Results from the HVTN 073E Phase I Vaccine Trial. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2013. p. A171–A171.

Morris, L., et al. “Boosting Antibody Responses with gp140 Protein Two Years After DNA/MVA Priming: Results from the HVTN 073E Phase I Vaccine Trial.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 29, no. 11, MARY ANN LIEBERT, INC, 2013, pp. A171–A171.

Morris L, Mkhize NN, Hermanus T, Chung E, Sato A, Grant S, Gu N, Williamson C, Williamson A, Barnett S, Bekker L, Allen M, Pensiero MN, Hural J, McElrath J, Elizaga M, Mayer K, Tomaras G, Montefiori D, Gray G. Boosting Antibody Responses with gp140 Protein Two Years After DNA/MVA Priming: Results from the HVTN 073E Phase I Vaccine Trial. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2013. p. A171–A171.